Warning: The NCBI web site requires JavaScript to function. more...
Epidemiological models for the spread of anti-malarial resistance.
Koella JC, Antia R.
Malar J. 2003 Feb 19;2:3. Epub 2003 Feb 19.
Related citations
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.
Malar J. 2008 Nov 2;7:229.
A model for transmission of partial resistance to anti-malarial drugs.
Tasman H, Soewono E, Sidarto KA, Syafruddin D, Rogers WO.
Math Biosci Eng. 2009 Jul;6(3):649-61.
A model for the origins and spread of drug-resistant malaria.
Hastings IM.
Parasitology. 1997 Aug;115 ( Pt 2):133-41.
The evolution of multiple drug resistance in malaria parasites.
Mackinnon MJ, Hastings IM.
Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):188-95. Review.
Drug resistance models for malaria.
Mackinnon MJ.
Acta Trop. 2005 Jun;94(3):207-17. Review.
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.
Smith DL, Klein EY, McKenzie FE, Laxminarayan R.
Malar J. 2010 Jul 23;9:217.
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
Klein EY, Smith DL, Boni MF, Laxminarayan R.
Malar J. 2008 Apr 25;7:67.
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.
O'Meara WP, Smith DL, McKenzie FE.
PLoS Med. 2006 May;3(5):e141. Epub 2006 Apr 4.
Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas.
Chiyaka C, Garira W, Dube S.
Theor Popul Biol. 2009 Feb;75(1):14-29. Epub 2008 Oct 25.
Intensity of malaria transmission and the evolution of drug resistance.
Hastings IM, Watkins WM.
Acta Trop. 2005 Jun;94(3):218-29. Epub 2005 Apr 19. Review.
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP.
Malar J. 2009 Nov 11;8:253.
A model for the coevolution of immunity and immune evasion in vector-borne diseases with implications for the epidemiology of malaria.
Koella JC, Boëte C.
Am Nat. 2003 May;161(5):698-707. Epub 2003 Mar 21.
Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
Babiker HA, Hastings IM, Swedberg G.
Expert Rev Anti Infect Ther. 2009 Jun;7(5):581-93. Review.
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI, White NJ.
Acta Trop. 2005 Jun;94(3):230-40. Review.
An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance.
Schneider KA, Kim Y.
Theor Popul Biol. 2010 Sep;78(2):93-108. Epub 2010 Jun 19.
Modelling a predictable disaster: the rise and spread of drug-resistantmalaria.
Hastings IM, D'Alessandro U.
Parasitol Today. 2000 Aug;16(8):340-7. Review.
Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model.
Chitnis N, Hyman JM, Cushing JM.
Bull Math Biol. 2008 Jul;70(5):1272-96. Epub 2008 Feb 22.
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.
Hallett RL, Sutherland CJ, Alexander N, Ord R, Jawara M, Drakeley CJ, Pinder M, Walraven G, Targett GA, Alloueche A.
Antimicrob Agents Chemother. 2004 Oct;48(10):3940-3.
A unique methodology for detecting the spread of chloroquine-resistant strains of Plasmodium falciparum, in previously unreported areas, by analyzing anophelines of malaria endemic zones of Orissa, India.
Mohanty A, Swain S, Singh DV, Mahapatra N, Kar SK, Hazra RK.
Infect Genet Evol. 2009 Jul;9(4):462-7. Epub 2009 Jan 20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on